Holdsworth-Carson SJ, et al. Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. Mol Hum Reprod. 2014;20(3):250–9.
Article CAS PubMed Google Scholar
Jamaluddin MFB, Nahar P, Tanwar PS. Proteomic characterization of the extracellular matrix of human uterine fibroids. Endocrinology. 2018;159(7):2656–69.
Article CAS PubMed Google Scholar
Stewart EA, Nowak RA. Uterine fibroids: hiding in plain sight. Physiology (Bethesda). 2022;37(1):16–27.
Rogers R, et al. Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol. 2008;198(4):474.e1-11.
Islam MS, et al. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24(1):59–85.
Article CAS PubMed Google Scholar
Marsh EE, et al. Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women. J Womens Health (Larchmt). 2018;27(11):1359–67.
Stewart EA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–12.
Article CAS PubMed Google Scholar
Flynn M, et al. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195(4):955–64.
Laughlin-Tommaso SK, et al. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause. 2018;25(5):483–92.
Article PubMed PubMed Central Google Scholar
Laughlin-Tommaso SK, et al. Long-term risk of de novo mental health conditions after hysterectomy with ovarian conservation: a cohort study. Menopause. 2020;27(1):33–42.
Article PubMed PubMed Central Google Scholar
Laughlin-Tommaso SK, et al. Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation. Menopause. 2016;23(2):121–8.
Article PubMed PubMed Central Google Scholar
Tuesley KM, et al. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality. Am J Obstet Gynecol. 2020;223(5):723.e1-723.e16.
Farland LV, et al. Hysterectomy with and without oophorectomy, tubal ligation, and risk of cardiovascular disease in the nurses’ health study II. J Womens Health (Larchmt). 2023;32(7):747–56.
Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:13–24.
Darnell JE Jr. STATs and gene regulation. Science. 1997;277(5332):1630–5.
Article CAS PubMed Google Scholar
Harrison DA. The Jak/STAT pathway. Cold Spring Harb Perspect Biol. 2012;4(3):a011205.
Article PubMed PubMed Central Google Scholar
Liu J, Wang F, Luo F. The Role of JAK/STAT pathway in fibrotic diseases: molecular and cellular mechanisms. Biomolecules. 2023;13(1):119.
Article CAS PubMed PubMed Central Google Scholar
Thomas SJ, et al. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015;113(3):365–71.
Article CAS PubMed PubMed Central Google Scholar
Malik M, et al. Cross-talk between Janus kinase-signal transducer and activator of transcription pathway and transforming growth factor beta pathways and increased collagen1A1 production in uterine leiomyoma cells. F S Sci. 2020;1(2):206–20.
Huang D, et al. Inhibiting effect of miR-29 on proliferation and migration of uterine leiomyoma via the STAT3 signaling pathway. Aging (Albany NY). 2022;14(3):1307–20.
Article CAS PubMed Google Scholar
Plimack ER, et al. AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors. Oncologist. 2013;18(7):819–20.
Article PubMed PubMed Central Google Scholar
Hedvat M, et al. The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell. 2009;16(6):487–97.
Article CAS PubMed PubMed Central Google Scholar
Hassan MH, et al. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am J Obstet Gynecol. 2008;199(2):156.e1-8.
Tsuiji K, et al. Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice. Tohoku J Exp Med. 2010;222(1):55–61.
Fritsch M, et al. Application of a patient derived xenograft model for predicative study of uterine fibroid disease. PLoS One. 2015;10(11):e0142429.
Article PubMed PubMed Central Google Scholar
Borahay MA, et al. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study. Am J Obstet Gynecol. 2015;213(2):196.e1-8.
Article CAS PubMed Google Scholar
Suzuki Y, et al. Establishment of a novel mouse xenograft model of human uterine leiomyoma. Sci Rep. 2018;8(1):8872.
Article PubMed PubMed Central Google Scholar
Malik M, Britten J, Catherino WH. Development and validation of hormonal impact of a mouse xenograft model for human uterine leiomyoma. Reprod Sci. 2020;27(6):1304–17.
Article CAS PubMed Google Scholar
Corachán A, et al. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model. Fertil Steril. 2020;113(1):205-216.e4.
Sápi J, et al. Tumor volume estimation and quasi-continuous administration for most effective bevacizumab therapy. PLoS One. 2015;10(11):e0142190.
Article PubMed PubMed Central Google Scholar
McFarland BC, et al. Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Mol Cancer Ther. 2011;10(12):2384–93.
Article CAS PubMed PubMed Central Google Scholar
Xin H, et al. Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480. Cancer Res. 2011;71(21):6601–10.
Article CAS PubMed PubMed Central Google Scholar
Gritsina G, et al. Targeted Blockade of JAK/STAT3 signaling inhibits ovarian carcinoma growth. Mol Cancer Ther. 2015;14(4):1035–47.
Article CAS PubMed PubMed Central Google Scholar
Jones CP, Boyd KL, Wallace JM. Evaluation of mice undergoing serial oral gavage while awake or anesthetized. J Am Assoc Lab Anim Sci. 2016;55(6):805–10.
Comments (0)